The Manifold Economic Impact of Multiple Sclerosis – Indirect and Direct Costs of Managing Patients
David W Brandes, Peter Rieckmann
Abstract Multiple sclerosis (MS) is associated with a significant economic burden, not only in terms of direct costs (drugs, hospital admissions, healthcare aids), but also indirect costs including loss of income, reduction of productivity, burden on caregivers and family members, and a reduction in patient quality of life (QoL). The disease has a marked effect […]